Cargando…
A Case of Symptomatic Supratherapeutic International Normalized Ratio on Rivaroxaban
Rivaroxaban is a direct oral anticoagulant that works by inhibiting factor Xa. Direct anticoagulants have largely replaced direct vitamin K inhibitors (VKAs) due to the decreased risk of major hemorrhages and the lack of need for regular monitoring and dose adjustments. However, there have been mult...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Cureus
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259092/ https://www.ncbi.nlm.nih.gov/pubmed/37313284 http://dx.doi.org/10.7759/cureus.40282 |